{"id":334213,"date":"2026-11-01T15:41:57","date_gmt":"2026-11-01T10:11:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/sai-parenteral-s-q2-results-fy27-pat-11-crore\/"},"modified":"2026-11-01T15:41:57","modified_gmt":"2026-11-01T10:11:57","slug":"sai-parenteral-s-q2-results-fy27-pat-11-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sai-parenteral-s-q2-results-fy27-pat-11-crore\/","title":{"rendered":"Sai Parenteral’s Q2 Results FY27: PAT Up 32.7% QoQ to Rs 10.51 Cr, Revenue Rs 194.02 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Sai Parenteral’s Q2 Results FY27 were declared on 1 November 2026 on a Consolidated basis. Revenue stood at Rs 194.02 Cr, up 8.59% QoQ from Rs 178.67 Cr in the previous quarter, while net profit reached Rs 10.51 Cr, up 32.7% QoQ from Rs 7.92 Cr. These quarterly results also show Operating Profit at Rs 39.34 Cr, and the QoQ growth of 67.26% is the largest percentage move among the three profit and revenue lines.<\/p>\n<\/div>\n

Sai Parenteral’s Ltd<\/a> (SAIPARENT) Q2 Results FY27 announced on 1 November 2026, covering the company’s financial performance for the July to September quarter. The consolidated results report revenue of Rs 194.02 Cr and net profit of Rs 10.51 Cr, and Sai Parenteral’s Q2 Results FY27 compare both lines with the previous quarter. The results date of 1 November 2026 anchors every comparison, and each figure traces to the filing made to NSE and BSE.<\/p>\n

This results analysis of Sai Parenteral’s Q2 Results covers the financial highlights, the business drivers, the outlook and the risks, using Univest data for the quarter. The Financial Highlights table follows directly and sets out the key numbers before the narrative begins.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n